Australia markets closed

Cocrystal Pharma, Inc. (8CC.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
1.4500+0.0500 (+3.57%)
At close: 08:02AM CEST
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-17,984
-17,984
-38,837
-14,185
-9,648
Depreciation & amortisation
-1,388
-1,388
388
382
157
Stock-based compensation
801
801
855
724
662
Change in working capital
2,342
2,342
-2,712
170
-878
Accounts receivable
-
-
0
556
88
Other working capital
-14,784
-14,784
-21,509
-12,771
-10,070
Other non-cash items
1,563
1,563
-209
239
-177
Net cash provided by operating activities
-14,666
-14,666
-21,435
-12,719
-9,830
Cash flows from investing activities
Investments in property, plant and equipment
-118
-118
-74
-52
-240
Net cash used for investing activities
-118
-118
-74
-52
-240
Cash flows from financing activities
Debt repayment
-7
-7
-27
-39
-121
Common stock issued
4,000
4,000
0
38,505
35,783
Net cash used provided by (used for) financing activities
3,993
3,993
-27
38,466
35,662
Net change in cash
-10,791
-10,791
-21,536
25,695
25,592
Cash at beginning of period
37,219
37,219
58,755
33,060
7,468
Cash at end of period
26,428
26,428
37,219
58,755
33,060
Free cash flow
Operating cash flow
-14,666
-14,666
-21,435
-12,719
-9,830
Capital expenditure
-118
-118
-74
-52
-240
Free cash flow
-14,784
-14,784
-21,509
-12,771
-10,070